HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 494 filers reported holding HORIZON THERAPEUTICS PUB L in Q4 2020. The put-call ratio across all filers is 0.36 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,284,348 | -28.3% | 37,033 | -36.2% | 0.04% | -21.3% |
| Q2 2023 | $5,972,396 | -20.1% | 58,069 | -15.3% | 0.05% | -25.4% |
| Q1 2023 | $7,479,036 | -16.6% | 68,527 | -13.1% | 0.06% | -20.3% |
| Q4 2022 | $8,972,447 | +61.0% | 78,844 | -12.4% | 0.08% | +54.9% |
| Q3 2022 | $5,572,000 | -19.0% | 90,025 | +4.4% | 0.05% | -5.6% |
| Q2 2022 | $6,875,000 | -10.0% | 86,192 | +18.7% | 0.05% | +17.4% |
| Q1 2022 | $7,637,000 | -20.0% | 72,590 | -18.0% | 0.05% | -8.0% |
| Q4 2021 | $9,541,000 | -14.4% | 88,535 | -12.9% | 0.05% | -25.4% |
| Q3 2021 | $11,140,000 | +35.6% | 101,694 | +15.9% | 0.07% | +39.6% |
| Q2 2021 | $8,213,000 | +1.8% | 87,713 | +0.1% | 0.05% | -9.4% |
| Q1 2021 | $8,064,000 | +21.9% | 87,610 | -3.1% | 0.05% | +29.3% |
| Q4 2020 | $6,614,000 | -0.9% | 90,414 | +5.2% | 0.04% | -14.6% |
| Q3 2020 | $6,677,000 | +0.7% | 85,948 | -27.9% | 0.05% | -5.9% |
| Q2 2020 | $6,630,000 | +1844.3% | 119,274 | +935.8% | 0.05% | +1600.0% |
| Q1 2020 | $341,000 | +11.4% | 11,515 | +36.0% | 0.00% | +50.0% |
| Q4 2019 | $306,000 | – | 8,465 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |